VALIDATION IMAGES
Flow cytometric analysis of HL-60 cells with TNF Receptor II (7D3) Monoclonal Antibody (bsm-52938R) at 1:50 dilution (red) compared with an unlabeled control (cells without incubation with primary antibody; black)
Lane 1: MCF-7 cells lysates; Lane 2: Jurkat cells lysates; Probed with TNF Receptor II (7D3) Monoclonal Antibody (bsm-52938R) at 1:500 overnight at 4°C followed by a conjugated secondary antibody for 60 minutes at 37°C.
IF(ICC) staining with TNF Receptor II (7D3) Monoclonal Antibody (bsm-52938R) at 1:100 in MCF-7 cells (red). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
IF(ICC) staining with TNF Receptor II (7D3) Monoclonal Antibody (bsm-52938R) at 1:100 in SW480 cells (red). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
Paraformaldehyde-fixed and paraffin-embedded Human uterus tissue incubated with TNF Receptor II (7D3) Monoclonal Antibody (bsm-52938R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Lane 1: Human THP-1 cell lysates; Lane 2: Human K562 cell lysates; Lane 3: Human U937 cell; Lane 4: Human U87MG cell;Lane 5: Human HUVEC cell. Probed with TNFR2 monoclonal Antibody, unconjugated (bsm-52938R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.